(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 50.7MM | +3% |
Gross Profit | 32.1MM | +5% |
Cost Of Revenue | 18.6MM | -1% |
Operating Income | 5.3MM | +26% |
Operating Expenses | 26.8MM | - |
Net Income | 3.5MM | +19% |
R&D | 651K | +10% |
G&A | 23.9MM | +1% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
LAFAYETTE, La., April 23, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Tuesday, May 7, 2024 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free)+1 201-689-8451 (International) Financial professionals are invited to call in to register in adv
LAFAYETTE, La., April 02, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced the finalization of its strategic partnership with East Alabama Health (“EAH”), providing Viemed with the controlling interest of East Alabama HomeMed, LLC ("HomeMed"). HomeMed provides home medical equipment services to patients within the EAH network as well as those in the su
Viemed Healthcare, Inc. ( NASDAQ:VMD ), is not the largest company out there, but it led the NASDAQCM gainers with a...
Robust Revenue Growth and Net Income Surge Highlight Year-End Achievements
LAFAYETTE, La., March 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2023. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended December 31, 2023 reached a new Company record of $50.7 million representing an increas
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Key Insights Institutions' substantial holdings in Viemed Healthcare implies that they have significant influence over...
Passive investing in index funds can generate returns that roughly match the overall market. But the truth is, you can...
Wasatch Global Investors, an investment management firm, released its “Wasatch Micro Cap Value Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed its benchmark during the quarter. The quality-oriented positioning was the main reason for the strategy’s outperformance in the quarter. In addition, please check the fund’s […]
Key Insights Viemed Healthcare's estimated fair value is US$15.02 based on 2 Stage Free Cash Flow to Equity Viemed...